Tharimmune, Inc. Annual Operating Income (Loss) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tharimmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • Tharimmune, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.85M, a 52% decline year-over-year.
  • Tharimmune, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$12.4M, a 31.5% decline year-over-year.
  • Tharimmune, Inc. annual Operating Income (Loss) for 2024 was -$12.4M, a 31.5% decline from 2023.
  • Tharimmune, Inc. annual Operating Income (Loss) for 2023 was -$9.46M, a 37.4% decline from 2022.
  • Tharimmune, Inc. annual Operating Income (Loss) for 2022 was -$6.88M, a 115% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$12.4M -$2.98M -31.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-26
2023 -$9.46M -$2.57M -37.4% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-26
2022 -$6.88M -$3.67M -115% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$3.21M -$1.4M -77.4% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-05-22
2020 -$1.81M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.